+Search query
-Structure paper
Title | Omecamtiv mecarbil and Mavacamten target the same myosin pocket despite antagonistic effects in heart contraction. |
---|---|
Journal, issue, pages | Biorxiv, Year 2023 |
Publish date | Oct 26, 2023 (structure data deposition date) |
Authors | Auguin, D. / Robert-Paganin, J. / Rety, S. / Kikuti, C. / David, A. / Theumer, G. / Schmidt, A.W. / Knolker, H.J. / Houdusse, A. |
External links | Biorxiv / PubMed:38014327 |
Methods | X-ray diffraction |
Resolution | 1.8 - 2.759 Å |
Structure data | PDB-8qyp: PDB-8qyq: PDB-8qyr: PDB-8qyu: |
Chemicals | ChemComp-ADP: ChemComp-VO4: ChemComp-MG: ChemComp-HOH: ChemComp-BEF: ChemComp-XB2: ChemComp-FMT: ChemComp-GOL: ChemComp-SO4: ChemComp-EDO: ChemComp-DMS: ChemComp-2OW: ChemComp-MLA: |
Source |
|
Keywords | CONTRACTILE PROTEIN / cardiac myosin modulators inherited cardiomyopathies / cardiac myosin modulators inherited cardiomyopathies mavcamten / cardiac myosin modulators inherited cardiomyopathies mavacamten / cardiac myosin modulators inherited cardiomyopathies Omecamtiv mecarbil |